论文部分内容阅读
1用药原则1.1用药依据应根据是否已有冠心病或脑卒中等危症,以及有无心血管疾病危险因素,结合血脂水平进行全面评价,确定治疗方案和血脂控制目标。1.2个体化用药在开始应用调脂药治疗以及拟定目标值时,需要考虑患者是否同时并存其他冠心病危险因素。不同人群药物治疗的低密度脂蛋白
1 principles of medication 1.1 medication should be based on whether there is coronary heart disease or stroke and other risk factors, as well as the risk factors for cardiovascular disease, combined with blood lipids to conduct a comprehensive evaluation to determine the treatment options and lipid control goals. 1.2 individualized medication at the beginning of the application of lipid-lowering drug treatment and to develop the target value, the need to consider whether the patient coexist with other risk factors for coronary heart disease. Different population drug treatment of low density lipoprotein